PE/Cyanine7 anti-mouse IL-4 Antibody

Pricing & Availability
Clone
11B11 (See other available formats)
Regulatory Status
RUO
Other Names
Interleukin-4, Ia inducing factor (IaIF), B cell stimulating factor-1 (BSF-1), Hodgkin's cell growth factor (HCGF), Mast cell growth factor-2 (MCGF-2), Macrophage fusion factor (MFF), T cell growth factor-2 (TCGF-2)
Isotype
Rat IgG1, κ
11B11_BV421_IL-4_Antibody_1_041024
PMA+ionomycin-stimulated (in presence of Brefeldin A for 6 hours) Th2-polarized C57BL/6 mouse CD4+ T cells were surface stained with CD3 and then intracelluarly stained with IL-4 (clone 11B11) PE/Cyanine7 (left) or rat IgG1, κ PE/Cyanine7 isotype control (right).
  • 11B11_BV421_IL-4_Antibody_1_041024
    PMA+ionomycin-stimulated (in presence of Brefeldin A for 6 hours) Th2-polarized C57BL/6 mouse CD4+ T cells were surface stained with CD3 and then intracelluarly stained with IL-4 (clone 11B11) PE/Cyanine7 (left) or rat IgG1, κ PE/Cyanine7 isotype control (right).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability
504117 25 µg $129.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
504118 100 µg $335.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IL-4 is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. IL-4 is a potent lymphoid cell growth factor which stimulates the growth and activation of certain B cells and T cells. IL-4 is important for regulation of T helper subset development.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Partially purified native mouse IL-4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume.  It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

ELISA1,2,10,13 or ELISPOT5 Capture: The purified 11B11 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with the biotinylated BVD6-24G2 antibody (Cat. No. 504202) as the detecting antibody and recombinant mouse IL-4 (Cat. No. 575609) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture.
Neutralization1-2,9,12: The 11B11 antibody can neutralize the bioactivity of natural or recombinant IL-4. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IL-4 bioactivity in vivo and in vitro (Cat. No. 504108).
Additional reported applications (for the relevant formats) include: immunoprecipitation16, immunohistochemical staining of formalin-fixed paraffin-embedded tissue sections8 and paraformaldehyde-fixed, saponin-treated frozen tissue sections6,7, and immunocytochemistry4.
Note: For testing mouse IL-4 in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 431101 to 431106) are specially developed and recommended.

Application References

(PubMed link indicates BioLegend citation)
  1. Shirai A, et al. 1994. Cytokine 6:329. (ELISA, Neut)
  2. Abrams J. 1995. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.20. (ELISA, Neut)
  3. Assenmacher M, et al. 1994. Eur. J. Immunol. 24:1097.
  4. Openshaw P, et al. 1995. J. Exp. Med. 182:1357. (ICC)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons New York. Unit 6.19. (ELISA Capture)
  6. Litton M, et al. 1994. J. Immunol. Methods 175:47. (IHC)
  7. Andersson U, et al. 1999. Detection and quantification of gene expression. New York:Springer-Verlag. (IHC)
  8. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  9. Hara M, et al. 2001. J. Immunol. 166:3789. (Neut)
  10. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  11. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  12. Wang W, et al. 2007. J. Immunol. 178:4885. (Neut)
  13. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  14. Ohnmacht C, et al. 2008. Blood 113:2816. PubMed
  15. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  16. Zavorotinskaya T, et al. 2003. Mol. Ther. 7:155. (IP)
Product Citations
  1. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  2. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  3. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  4. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  5. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  6. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  7. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  8. Wang W, et al. 2020. Br J Pharmacol. 177:5569. PubMed
  9. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  10. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  11. Alves C, et al. 2015. PLoS One. 10: 0142972. PubMed
  12. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  13. Dai G, et al. 2021. mSphere. 6: . PubMed
  14. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  15. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  16. Jiang J, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1261-9. PubMed
  17. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  18. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  19. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  20. Garcia-Dominguez D, et al. 2022. Front Immunol. 13:948335. PubMed
  21. Voigt A, et al. 2015. Biol Open. 10.1242/bio.013771. PubMed
  22. Wang Y, et al. 2021. Front Immunol. 11:601601. PubMed
  23. Smith R, et al. 2016. J Leukoc Biol. 100:371-80. PubMed
  24. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  25. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
RRID
AB_10895747 (BioLegend Cat. No. 504117)
AB_10895747 (BioLegend Cat. No. 504118)

Antigen Details

Structure
Cytokine; 15-19 kD (Mammalian)
Bioactivity
Differentiation of naïve CD4+ T cells to the TH2 type, proliferation/differentiation of activated B cells, expression of class II MHC antigens, and of low affinity IgE receptors in resting B cells
Cell Sources
Mast cells, T cells, bone marrow stromal cells
Cell Targets
B cells, T cells, monocytes, endothelial cells, fibroblasts
Receptors
Heterodimer IL-4Rα (CD124); γ-subunit (CD132) in common with IL-2R, IL-7R, IL-13R, IL-15R
Cell Type
Tregs
Biology Area
Immunology
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Boulay J, et al. 1992. Curr. Opin. Immunol. 4:294.
3. Dullens H, et al. 1991. In vivo 5:567.
4. Paul W. 1991. Blood 77:1859.

Regulation
Upregulated by IL-2, platelet activating factor; downregulated by TGF-β
Gene ID
16189 View all products for this Gene ID
UniProt
View information about IL-4 on UniProt.org
Go To Top Version: 2    Revision Date: 07/11/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account